Member Info for _Mr_Big

Thanks.

At the risk of sounding like a deramper, who is responsible for funding Activ-2 trial?
I.e. Is there any risk we'll need another placing to fund our participation in it?

Thanks.

Why haven't Polar bought these extra tickets at 80p when they had the chance?...

Not sure they choose when to publish this one - it goes live as soon as the notification from Polar is in?

Not quite. Presumably, we still have some of the £87m cash in the bank, which needs to be factored into the SP.

RM said his expectation was that it would take 2-6 months from start of trial. Interim review unlikely, but possible if recruitment is very slow.

Realistically, 4 months to recruit, dose, collect data and analyse?
I was excited about trial size being reduced, but if trial delay is due to that reduction, one wonders if it was the right choice. Compare start of 900 trial in mid November vs 600-trial in mid January... We'll never know what really happened there, but if activ-2 doesn't come through, be are buggered imho.

If activ-2 rumours are true, P3 is not that important, as there will be a high likelihood that we get EUA before P3 is complete.

probably only the vulnerable, as ifn will be in short supply

I hope it's not these supplements that are going on activ 2

And the cat was saying 6.99...

I'll give her another month in case she was referring to end of Chinese year.

Happy Birthday!

They will only report what the Masters let them report.

Made a T.t of myself waiting for this to drop to 120...

I think this one went under our radar?

https://www.livemint.com/news/india/zydus-cadila-s-covid-19-therapy-pegihep-completes-phase-ii-trial-11605160568754.html

Successful completion of P2. Yet another piece of evidence that ifn works...

Please, not another golf thread!

Thank you for the summary - it was the senate testimony that made me add more a few weeks ago.

Just please don't use the "i" word ;)

Numis think it's still possible, as they have re-instated their guidance, and that was before FDA fast track.

I think we've missed the boat with £50. £15-£20, perhaps, is still achievable. It's not how many % sp will rise from now, it's more about the future order book. Still huge potential, but we've been stalling for so long, by the time we hit the market, we'll be running against other effective treatments and feeling the impact from vax.

I think we are overdue a TR1...

Hopefully, a meaty RNS: interim home trial results, FDA EUA on the back of it and pre-order of 500k treatments to start saving lives.
But I'll be happy with a takeover offer from Sun Pharma too.

Why bother trying to make some cash on SNG if we're all going to kick the bucket by Q1 2122 anyway.

POS operate in fossil fuels & distribution sector - nothing to do with pharma.

Whether they work or not, what we have is a bunch of people who have opted to receive a tested (albeit poorly) treatment. After receiving half of it, they are now being told that they will act as Guinea pigs for a new medical trial. This has got to violate a few human rights I'd think.
At the same time, it seems that we're being denied access to SNG001 under a MAP, even if we offer to pay for it ourselves.